SuperworthBlend Labs BLND
- Market cap
- $276.7M
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 2.1×
- EV/EBIT
- n/m
- a loss over the last year
- Revenue, 12 months
- $129.2M
- +6% on a year ago
- Net margin
- −3.0%
- Free cash flow yield
- 2.7%
Blend Labs trades at 2.1× sales. Its trailing earnings are negative, so it has no PE. Revenue was $129.2M over the last twelve months, up 6% on a year earlier with a −3% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $40.6M−27% | $36.1M−16% | $23.8M−36% | $28.7M−33% | $33.1M−18% | $30.1M−17% | $26.8M+13% | $31.6M+10% | $32.9M−1% | $31.6M+5% | $30.8M+15% | $33.8M+7% | |
| Cost of revenue | $18.5M−46% | $16.4M−42% | $7.8M−64% | $8.4M−57% | $8.6M−54% | $7.8M−53% | $7.8M+1% | $8.3M−1% | $8.4M−2% | $8.3M+6% | $7.5M−5% | $9M+8% |
| Gross profit | $22.1M+5% | $19.7M+37% | $16M+1% | $20.3M−13% | $24.5M+11% | $22.3M+13% | $19M+18% | $23.4M+15% | $24.5M−0% | $23.4M+5% | $23.4M+23% | $24.9M+7% |
| R&D | $18.8M−45% | $14.4M−57% | $14.2M−46% | $12.9M−42% | $10.1M−46% | $8.9M−39% | $7.8M−45% | $7.5M−42% | $8.5M−16% | $7.5M−16% | $9.4M+20% | $8.7M+16% |
| SG&A | $30.3M−42% | $26.5M−50% | $22.1M−42% | $20.4M−43% | $21M−31% | $16.7M−37% | $18.4M−17% | $20.7M+1% | $20.8M−1% | $20.7M+24% | $18.4M−0% | $17.8M−14% |
| −$36.2M−72% | −$21.9M−71% | −$21.2M−66% | −$13.1M−64% | −$11.3M−69% | −$3.3M−85% | −$8M−62% | −$4.8M−63% | −$4.9M−57% | −$4.8M+48% | −$5.1M−37% | −$1.6M−67% | |
| Interest expense | $8.2M+33% | $7.1M−4% | $5.1M−33% | $1.6M−79% | $0 | $0 | $0 | $0 | $0 | $0 | n/a | n/a |
| Pre-tax income | −$41.8M−69% | −$30.4M−62% | −$20.7M−69% | −$19.2M−54% | −$610K−99% | −$2.2M−93% | −$6.9M−67% | −$3.8M−80% | $12.4M | −$3.8M+73% | −$5M−27% | −$1.4M−64% |
| $44K+214% | −$74K | $42K−41% | $30K−43% | $21K−52% | $16K | $30K−29% | $41K+37% | $27K+29% | $41K+156% | $63K+110% | $119K+190% | |
| Net income | −$41.8M−67% | −$30.3M−62% | −$20.7M−68% | −$19.4M−53% | −$2.4M−94% | −$825K−97% | −$9.5M−54% | −$6.8M−65% | $12.5M | −$6.8M+730% | −$8M−15% | −$1.5M−78% |
| −$0.18−68% | −$0.13−63% | −$0.08−71% | −$0.09−50% | −$0.03−83% | −$0.03−77% | −$0.06−25% | −$0.04−56% | $0.02 | −$0.04+33% | −$0.05−17% | −$0.03−25% | |
| 246.4M+5% | 248.6M+4% | 250.9M+4% | 253.1M+4% | 254.9M+3% | 256.7M+3% | 258.8M+3% | 259.2M+2% | 268.7M+5% | 258.1M+1% | 255.6M−1% | 239.9M−7% |
Revenue: Q1 FY20 and Q1 FY21: 6 months less the 3 months printed beside them.
Cost of revenue: Q1 FY20 and Q1 FY21: 6 months less the 3 months printed beside them.
Gross profit: Q1 FY20 and Q1 FY21: 6 months less the 3 months printed beside them.
R&D: Q1 FY20 and Q1 FY21: 6 months less the 3 months printed beside them.
SG&A: Q1 FY20 and Q1 FY21: 6 months less the 3 months printed beside them.
Operating income: Q1 FY20 and Q1 FY21: 6 months less the 3 months printed beside them.
Pre-tax income: Q1 FY20 and Q1 FY21: 6 months less the 3 months printed beside them.
Income tax: Q1 FY20 and Q1 FY21: 6 months less the 3 months printed beside them.
Net income: Q1 FY20 and Q1 FY21: 6 months less the 3 months printed beside them.
EPS, diluted: 7 periods, Q1 FY20 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: Q1 FY20: share-days: the 6-month average less the second quarter's. 5 periods, Q4 FY20 to Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. Q4 FY21: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Software - Application nearest Blend Labs' size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| BLNDBlend Labs | $276.7M | n/m | n/a | 2.1× | +6% | −3.0% | |
| EGHT8X8 | $307.6M | 53.3× | 57.5× | 0.4× | +4% | 0.6% | |
| ZIPZiprecruiter | $382.4M | 13.3× | 30.9× | 0.8× | +0% | 6.2% | |
| OOMAOoma | $545.7M | 52.0× | 124× | 1.8× | +17% | 3.6% | |
| TRAKReposiTrak | $133.2M | 18.8× | 44.6× | 5.7× | +3% | 32.5% | |
| CARSCars.com | $585.6M | 19.2× | 27.3× | 0.8× | +1% | 4.7% | |
| IBEXIBEX | $627.1M | 15.1× | 11.5× | 1.0× | +15% | 7.2% | |
| NRDSNerdwallet | $698.7M | 12.3× | 15.9× | 0.8× | +12% | 7.6% | |
| MNTNMNTN | $724.1M | 12.9× | 15.1× | 2.3× | +21% | 18.0% | |
| YEXTYext | $727.5M | 38.7× | 48.3× | 1.6× | −1% | 5.9% | |
| TASKTaskUs | $784.8M | 7.4× | 26.3× | 0.6× | +11% | 8.8% | |
| Peer median | $606.4M | 16.9× | 29.1× | 0.9× | +8% | 6.7% |
More on Blend Labs
Each number over time
- PE ratio
- Price to sales ratio
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Its groups
About
- Industry
- Software - Application
- Sector
- Technology
Valuation data, not investment advice. Prices as of .